Leniolisib (Joenja)
Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS)
Approved/CommercialMarketed
Key Facts
Indication
Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS)
Phase
Approved/Commercial
Status
Marketed
Company
About Pharming Group
Pharming Group is a commercial-stage rare disease biopharmaceutical company with a mission to transform the lives of underserved patients. The company leverages its proven clinical development, supply chain, and commercial infrastructure to grow its existing portfolio and invest in long-term pipeline expansion. With a dual listing on Euronext Amsterdam (PHARM) and Nasdaq (PHAR), Pharming aims to become a leading global rare disease company through a combination of organic growth and strategic business development.
View full company profile